Barrick Announces Board Changes
Rhea-AI Summary
Barrick (NYSE:B) announced on November 26, 2025 that Ben van Beurden has stepped down as a director and as Lead Independent Director. Loreto Silva, an existing non-executive director, will succeed him as Lead Independent Director. The chairman said the board is focused on delivering long-term value and described the company as having industry-leading assets and a strengthened leadership team aligned on strategic priorities.
Positive
- None.
Negative
- None.
News Market Reaction – B
In the Nov 26 session, B gained 4.75%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Drug access update | Positive | +2.2% | Leqembi added to China commercial insurance innovative drug list. |
| Dec 08 | Clinical trial clearance | Positive | +2.2% | FDA cleared global Phase IIb trial for CS1 in PAH. |
| Dec 03 | Product launch | Positive | -1.3% | Launch of ETQ Reliance Go cloud-based quality management platform. |
| Dec 02 | Asset divestiture | Neutral | -3.1% | Completed Tongon mine sale with consideration up to $305 million. |
| Dec 01 | IPO evaluation | Positive | +2.4% | Board authorized evaluation of IPO for North American gold assets. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news skewed positive with mostly supportive price reactions; the main divergence was a selloff on the ETQ product launch headline.
Over early December 2025, B-linked headlines covered strategic and partner developments. The Board authorized exploring an IPO of North American gold assets, which saw a 2.39% gain. Barrick then completed the Tongon mine divestiture for up to $305 million, followed by a 3.07% decline. Separate partner and platform news around Leqembi’s inclusion in a Chinese insurance list and an FDA-cleared Phase IIb trial both coincided with 2.22% gains, while an ETQ software launch saw a modest 1.29% pullback.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) announced today that that Ben van Beurden has stepped down as a Director of the Board and Lead Independent Director. Loreto Silva, a current Non-Executive Director, will succeed as Lead Independent Director.
John Thornton, Chairman of the Board, said: “I would like to thank Ben for his contribution to Barrick and welcome Loreto to the role of Lead Independent Director. The Barrick Board remains focused on delivering long-term value for shareholders. The Company has industry-leading assets and a strengthened leadership team that is fully aligned on delivering our strategic priorities.”
About Barrick Mining Corporation
Barrick is a leading global mining, exploration and development company. With one of the largest portfolios of world-class and long-life gold and copper assets in the industry—including six of the world’s Tier One gold mines—Barrick’s operations and projects span 18 countries and five continents. Barrick is also the largest gold producer in the United States. We create real, long-term value for all stakeholders through responsible mining, strong partnerships and a disciplined approach to growth. Barrick shares trade on the New York Stock Exchange under the symbol ‘B’ and on the Toronto Stock Exchange under the symbol ‘ABX’.
Investor Relations Contact
Barrick Mining Corporation
Cleve Rueckert, +1 775 397 5443
cleveland.rueckert@barrick.com
Media Contact
Brunswick Group
Carole Cable, +44 (0) 7974 982 458
barrick@brunswickgroup.com
